We report a case of a 10-month-old Chinese female with EBV-associated HLH, who showed a progression to t-AML following etoposide therapy with cytogenetic abnormality for t (11; 19) (q23; p13) and MLL gene fusion, 23 months after the onset of HLH. Here, KMT2A is linked to hemophagocytic syndrome.